MR/PET: A new challenge in hybrid imaging

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 272-277

  Werner, Matthias K ^a   Schmidt, Holger ^a   Schwenzer, Nina F ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Hybrid imaging; MR PET; MRI; PET; PET MR

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3' FLUOROTHYMIDINE F 18; CHOLINE C 11; DOTATATE GA 68; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IMATINIB; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

BONE MARROW METASTASIS; BONE METASTASIS; BRAIN BLOOD FLOW; CONTRAST ENHANCEMENT; DEGENERATIVE DISEASE; DEMENTIA; DESMOID TUMOR; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FIBROMATOSIS; GLUCOSE METABOLISM; HUMAN; NEUROENDOCRINE TUMOR; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ATTENUATION; RADIATION DOSE; REVIEW; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; WHOLE BODY MRI;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 84864781074     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.8724     Document Type: Review

References (47)

1. Townsend DW. A combined PET/CT scanner: the choices. J Nucl Med 2001; 42:533-534
2. Krishnasetty V, Fischman AJ, Halpern EL, Aquino SL. Comparison of alignment of computer-registered data sets: combined PET/CT versus independent PET and CT of the thorax. Radiology 2005; 237:635-639 (Pubitemid 41507905)
3. Nakamoto Y, Tatsumi M, Cohade C, Osman M, Marshall LT, Wahl RL. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging 2003;30:597-602 (Pubitemid 36559839)
4. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002; 53:89-112 (Pubitemid 34177873)
5. 68Ga]-DOTATOC PET/CT in neuroendocrine tumors. Horm Metab Res 2010;42:599-606
6. 68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET. Eur J Nucl Med Mol Imaging 2011; 38:1967-1976
7. Fischer K, Sossi V, Schmid A, et al. Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice. J Nucl Med 2011; 52:1133-1141
8. Gourni E, Demmer O, Schottelius M, et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med 2011; 52:1803-1810
9. Boss A, Bisdas S, Kolb A, et al. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 2010; 51: 1198-1205
10. Boss A, Stegger L, Bisdas S, et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol 2011; 21:1439-1446
11. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007; 43:557-564
12. Etchebehere EC, Romanato JS, Santos AO, Buzaid AC, Camargo EE. Impact of [F-18] FDG-PET/CT in the restaging and management of patients with malignant melanoma. Nucl Med Commun 2010; 31:925-930
13. 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin 2007; 46:161-168; quiz, N47-N48
14. 18F-FDG PET/CT of cervical carcinoma. AJR 2011; 196:1225-1233
15. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238:272-279 (Pubitemid 43010605)
16. de Bazelaire C, Groheux D, Chapellier M, et al. Breast inflammation: indications for MRI and PET-CT. Diagn Interv Imaging 2012; 93:104-115
17. 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study. J Nucl Med 2011; 52:1526-1534
18. Floriani I, Torri V, Rulli E, et al. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 2010; 31:19-31
19. Heusner T, Golitz P, Hamami M, et al. "One-stopshop"staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Eur J Radiol 2011; 78:430-435
20. Paldino MJ, Barboriak DP. Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am 2009; 17:277-289
21. Giesel FL, Mehndiratta A, Locklin J, et al. Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. Exp Oncol 2009; 31:106-114
22. Schraml C, Schwenzer NF, Clasen S, et al. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation: initial results. J Magn Reson Imaging 2009; 29:1308-1316
23. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 2010; 32:2-16
24. Herholz K. PET studies in dementia. Ann Nucl Med 2003; 17:79-89 (Pubitemid 36693059)
25. Koepp MJ, Woermann FG. Imaging structure and function in refractory focal epilepsy. Lancet Neurol 2005; 4:42-53 (Pubitemid 40023235)
26. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000; 20:1276-1293
27. Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging 2009; 36(suppl 1):S121-S130
28. Sieren JC, Ohno Y, Koyama H, Sugimura K, McLennan G. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 2010; 32:1353-1369
29. Spira D, Weisel K, Brodoefel H, Schulze M, Kaufmann S, Horger M. Can whole-body lowdose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)? Acad Radiol 2012; 19:89-94
30. 18F-FDG PET/CT examinations. J Nucl Med 2005; 46:608-613
31. Pantos I, Thalassinou S, Argentos S, Kelekis NL, Panayiotakis G, Efstathopoulos EP. Adult patient radiation doses from non-cardiac CT examinations: a review of published results. Br J Radiol 2011; 84:293-303
32. Delso G, Furst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011; 52:1914-1922
33. Schulz V, Torres-Espallardo I, Renisch S, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 2011; 38:138-152
34. Zaidi H, Ojha N, Morich M, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 2011; 56:3091-3106
35. Delso G, Ziegler S. PET/MRI system design. Eur J Nucl Med Mol Imaging 2009; 36(suppl 1):S86-S92
36. Pfannenberg C, Konigsrainer I, Aschoff P, et al. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2009; 16:1295-1303
37. Judenhofer MS, Pichler BJ, Cherry SR. Evaluation of high performance data acquisition boards for simultaneous sampling of fast signals from PET detectors. Phys Med Biol 2005; 50:29-44 (Pubitemid 40185398)
38. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008; 14:459-465 (Pubitemid 351499385)
39. Pichler BJ, Judenhofer MS, Catana C, et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med 2006; 47:639-647 (Pubitemid 46768465)
40. Catana C, Procissi D, Wu Y, et al. Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci USA 2008; 105:3705-3710 (Pubitemid 351723462)
41. Du J, Carl M, Bydder M, Takahashi A, Chung CB, Bydder GM. Qualitative and quantitative ultrashort echo time (UTE) imaging of cortical bone. J Magn Reson 2010; 207:304-311
42. Hofmann M, Steinke F, Scheel V, et al. MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 2008; 49:1875-1883
43. Hofmann M, Bezrukov I, Mantlik F, et al. MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med 2011; 52:1392-1399
44. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 2009; 50:520-526
45. Eiber M, Souvatzoglou M, Pickhard A, et al. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction. Eur J Radiol [Epub 2011]
46. Rowland IJ, Peterson ET, Gordon JW, Fain SB. Hyperpolarized 13carbon MR. Curr Pharm Biotechnol 2010; 11:709-719
47. Heesakkers RA, Hovels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 2008; 9:850-856